Cannula for minimizing dilution of dosing during nitric oxide delivery

US10918819B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10918819-B2
Application numberUS-201715790300-A
CountryUS
Kind codeB2
Filing dateOct 23, 2017
Priority dateDec 4, 2012
Publication dateFeb 16, 2021
Grant dateFeb 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are nasal cannulas that improve the precision of the delivered dose for nitric oxide therapy by reducing the dilution of nitric oxide. The nasal cannulas may reduce the total volume and potential for retrograde flow during nitric oxide therapy through the design of the specific dimensions of the flow path and/or having check valves in the nitric oxide delivery line and/or having a flapper or umbrella valve dedicated to nitric oxide delivery. The nasal cannulas may also use materials that limit oxygen diffusion through the cannula walls. The nosepiece for these cannulas may be manufactured by a molding technique.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of administering nitric oxide for treating pulmonary hypertension, the method comprising: administering a pulse of a gas comprising nitric oxide to a patient in need thereof, wherein the pulse is administered through a nasal cannula comprising a cannula nosepiece comprising a nitric oxide flow path having a volume that is less than 20% of a volume of pulse of the gas comprising nitric oxide. 2. The method of claim 1 , wherein the nasal cannula comprises: a first lumen, a second lumen, and a third lumen: the first lumen being a first therapeutic gas lumen for delivering the gas comprising nitric oxide to the patient, the second lumen being a triggering lumen, and the third lumen being a second therapeutic gas lumen for delivering a gas comprising oxygen to the patient; and wherein the cannula nosepiece has separate flow paths to the patient for each of (i) the first therapeutic gas lumen, (ii) the triggering lumen, and (iii) the second therapeutic gas lumen. 3. The method of claim 1 , wherein the nitric oxide flow path comprises a first prong, a second prong and a prong spacing. 4. The method of claim 1 , wherein the nasal cannula comprises a first lumen for delivering the gas comprising nitric oxide to the patient and a second lumen, wherein the first lumen has a smaller inner diameter than an inner diameter of the second lumen. 5. The method of claim 1 , wherein the pulse of gas comprising nitric oxide has a volume less than 1 mL. 6. The method of claim 1 , wherein the nitric oxide flow path is less than 10% of the volume of pulse of the gas comprising nitric oxide. 7. The method of claim 1 , wherein the nitric oxide flow path has a volume less than or equal to 0.035 mL. 8. A method of administering nitric oxide for treating pulmonary hypertension, the method comprising: administering a plurality of pulses of a gas comprising nitric oxide to a patient in need thereof, wherein the plurality of pulses are administered through a nasal cannula comprising a cannula nosepiece comprising a nitric oxide flow path having a volume that is less than 20% of a volume of each of the plurality of pulses of the gas comprising nitric oxide. 9. The method of claim 8 , wherein the nasal cannula comprises: a first lumen, a second lumen, and a third lumen: the first lumen being a first therapeutic gas lumen for delivering a gas comprising nitric oxide to the patient, the second lumen being a triggering lumen, and the third lumen being a second therapeutic gas lumen for delivering a gas comprising oxygen to the patient; and wherein the cannula nosepiece has separate flow paths to the patient for each of (i) the first therapeutic gas lumen, (ii) the triggering lumen, and (iii) the second therapeutic gas lumen. 10. The method of claim 8 , wherein the nitric oxide flow path comprises a first prong, a second prong and a prong spacing. 11. The method of claim 8 , wherein the nasal cannula comprises a first lumen for delivering the gas comprising nitric oxide to the patient and a second lumen, wherein the first lumen has a smaller inner diameter than an inner diameter of the second lumen. 12. The method of claim 8 , wherein each of the plurality of pulses of the gas comprising nitric oxide has a volume less than 1 mL. 13. The method of claim 8 , wherein the nitric oxide flow path is less than 10% of the volume of each of the plurality of pulses of the gas comprising nitric oxide. 14. The method of claim 8 , wherein the nitric oxide flow path has a volume less than or equal to 0.035 mL. 15. A method of administering nitric oxide to a patient, the method comprising: administering a plurality of pulses of a gas comprising nitric oxide to the patient, wherein the plurality of pulses are administered through a nasal cannula comprising a cannula nosepiece comprising a nitric oxide flow path having a volume that is less than 20% of a volume of each of the plurality of pulses of the gas comprising nitric oxide. 16. The method of claim 15 , wherein the nasal cannula comprises: a first lumen, a second lumen, and a third lumen: the first lumen being a first therapeutic gas lumen for delivering a gas comprising nitric oxide to the patient, the second lumen being a triggering lumen, and the third lumen being a second therapeutic gas lumen for delivering a gas comprising oxygen to the patient; and wherein the cannula nosepiece has separate flow paths to the patient for each of (i) the first therapeutic gas lumen, (ii) the triggering lumen, and (iii) the second therapeutic gas lumen. 17. The method of claim 15 , wherein the nitric oxide flow path comprises a first prong, a second prong and a prong spacing. 18. The method of claim 15 , wherein the nasal cannula comprises a first lumen for delivering the gas comprising nitric oxide to the patient and a second lumen, wherein the first lumen has a smaller inner diameter than an inner diameter of the second lumen. 19. The method of claim 15 , wherein each of the plurality of pulses of the gas comprising nitric oxide has a volume less than 1 mL. 20. The method of claim 15 , wherein the nitric oxide flow path is less than 10% of the volume of each of the plurality of pulses of the gas comprising nitric oxide.

Assignees

Inventors

Classifications

  • Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves · CPC title

  • Oxygen · CPC title

  • Gas-saving devices therefor · CPC title

  • Respiratory or anaesthetic masks · CPC title

  • Pressure sampling ports · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10918819B2 cover?
Described are nasal cannulas that improve the precision of the delivered dose for nitric oxide therapy by reducing the dilution of nitric oxide. The nasal cannulas may reduce the total volume and potential for retrograde flow during nitric oxide therapy through the design of the specific dimensions of the flow path and/or having check valves in the nitric oxide delivery line and/or having a fla…
Who is the assignee on this patent?
Mallinckrodt Hospital Products Ip Ltd
What technology area does this patent fall under?
Primary CPC classification A61M16/0677. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).